Treatment of Vesicoureteral Reflux (VUR) in Children
The primary goal of VUR treatment is preservation of renal function, with initial management stratified by risk category: low-risk patients (low-grade VUR, normal kidneys, no symptoms) can be observed without antibiotics; moderate-risk patients require continuous antibiotic prophylaxis (CAP) with or without bladder/bowel dysfunction (BBD) treatment; and high-risk patients (high-grade VUR with abnormal kidneys) need CAP plus early consideration of surgical intervention, particularly if breakthrough infections occur. 1
Risk Stratification Framework
Treatment decisions must be based on multiple factors rather than VUR grade alone 1:
- Grade of reflux (I-V using International Reflux Study Committee classification) 1
- Renal parenchymal status (presence of cortical scarring on DMSA scan) 1
- Age and toilet-training status 1
- Presence of bladder and bowel dysfunction (BBD/LUTD) 1
- History of febrile UTIs 1
- Bilaterality of reflux 1
Treatment Approach by Risk Category
High-Risk Patients
Post-toilet training with grade IV-V VUR, abnormal kidneys, and LUTD:
- Initial treatment must always address LUTD first with urotherapy plus CAP 1
- Surgical intervention should be considered early if breakthrough infections occur or LUTD persists despite urotherapy 1
- Greater possibility of earlier intervention compared to other groups 1
Post-toilet training with grade IV-V VUR, abnormal kidneys, without LUTD:
- Surgical intervention should be considered as primary treatment 1
- Ureteral reimplantation has superior outcomes compared to endoscopic correction for high-grade reflux 1
Moderate-Risk Patients
Pre-toilet training infants with high-grade VUR and abnormal kidneys:
- CAP is the initial treatment regardless of reflux grade 1
- Spontaneous resolution rates are higher in males 1
- Surgical intervention considered only for breakthrough infections or persistent VUR 1
- Full re-evaluation after 12-24 months 1
Post-toilet training with high-grade VUR, normal kidneys, and LUTD:
- LUTD treatment is mandatory as first-line therapy with CAP 1
- If LUTD persists despite urotherapy, surgical intervention should be considered 1
- Follow-up focuses on UTI, LUTD, and kidney status with re-evaluation after successful urotherapy 1
Post-toilet training with low-grade VUR and abnormal kidneys:
- Treatment choice is controversial 1
- Endoscopic treatment may be an option (80-90% success rates for lower grades) 2
- LUTD treatment should be provided if present 1
Low-Risk Patients
Symptomatic patients with normal kidneys, low-grade VUR, no LUTD:
- Close surveillance without antibiotic prophylaxis is appropriate 1
- Alternative: CAP can be offered 1
- Parents must be informed about infection risk if no treatment is given 1
Asymptomatic patients (prenatal hydronephrosis or siblings) with low-grade VUR:
Continuous Antibiotic Prophylaxis (CAP) Details
Indications and dosing:
- Daily antibiotics at one-quarter to one-half the therapeutic dose 1
- Not needed in every VUR patient 1
- Particularly beneficial for infants with grade III-V VUR without previous UTIs 1
Evidence from PREDICT trial:
- CAP provided small but significant benefit in preventing first UTI in infants with grade III-V VUR 1
- Trade-off: increased non-E. coli organisms and antibiotic resistance 1
Practical approach:
- Continue CAP until BBD resolution 1
- More aggressive follow-up needed with re-evaluation after 6 months in high-risk patients 1
Surgical Management
Indications for Surgery
Strong indications:
- Frequent breakthrough febrile infections despite CAP 1, 3
- Persistent high-grade reflux (grades IV-V) with abnormal renal parenchyma 1
- Failure of conservative management in children >1 year with high-grade VUR and abnormal kidneys 1
- Parental preference for definitive therapy over conservative management 1
Surgical Options
Ureteral reimplantation (open or minimally invasive):
- Superior outcomes for high-grade reflux (grades IV-V) 1
- Success rates approaching 98% 4
- Reserved for persistent high-grade reflux 1
Endoscopic injection of bulking agents:
- Satisfactory results for lower-grade reflux 1
- Success rates 50-92% depending on grade 4
- Less invasive option 2
Critical Management of BBD/LUTD
All toilet-trained children must be carefully evaluated for BBD:
- Presence of both BBD and VUR doubles the risk of recurrent febrile UTI 1
- BBD treatment must always precede or accompany VUR treatment 1
- More intensive follow-up required until BBD resolves 3
Common Pitfalls to Avoid
Do not:
- Treat VUR without first addressing BBD in toilet-trained children 1
- Use the same approach for all VUR grades—treatment must be risk-stratified 1
- Continue conservative management if breakthrough febrile infections occur 3
- Perform routine postoperative VCUG—only on indication 1
Do:
- Inform parents that siblings have high VUR prevalence and may need screening 1, 3
- Provide immediate parenteral antibiotics for febrile breakthrough infections 1
- Monitor height, weight, blood pressure, and possibly serum creatinine during follow-up 1, 3
- Continue follow-up of kidney status until after puberty in high-risk cases 1